← Open Payments lookup

ANDREW BRAGAGNINI: Open Payments

NPI 1629672308 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,234 in 116 payments from 24 companies in 2025. Trend: 2023 $1,933 · 2024 $2,441 · 2025 $2,234

Food & beverage: $2,234
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.14$311
Amgen Inc.17$232
Otsuka America Pharmaceutical, Inc.9$184
Fresenius USA Marketing, Inc.9$150
Boehringer Ingelheim Pharmaceuticals, Inc.8$140
GlaxoSmithKline, LLC.8$127
Vifor Pharma, Inc.6$126
SHIELD THERAPEUTICS INC7$119
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$118
Bayer Healthcare Pharmaceuticals Inc.6$115

Products named: TARPEYO, KRYSTEXXA, JYNARQUE, JARDIANCE, VELPHORO, BENLYSTA, Veltassa, ACCRUFER.

Industry payments across LA — which companies pay providers there.